PTC Therapeutics to buy drug candidate from Sangamo for up to $211M
PTC Therapeutics plans to buy a drug candidate from Sangamo for up to $211M.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.